Pt(IV) Prodrugs with NSAIDs as Axial Ligands

A chemo-anti-inflammatory strategy is of interest for the treatment of aggressive cancers. The platinum (IV) prodrug with non-steroidal anti-inflammatory drugs (NSAIDs) as axial ligands is designed to efficiently enter tumor cells due to high lipophilicity and release the cytotoxic metabolite and NS...

Descripción completa

Detalles Bibliográficos
Autores principales: Spector, Daniil, Krasnovskaya, Olga, Pavlov, Kirill, Erofeev, Alexander, Gorelkin, Peter, Beloglazkina, Elena, Majouga, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067705/
https://www.ncbi.nlm.nih.gov/pubmed/33917027
http://dx.doi.org/10.3390/ijms22083817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067705/
https://www.ncbi.nlm.nih.gov/pubmed/33917027
http://dx.doi.org/10.3390/ijms22083817

Ejemplares similares